The top five tweets: From migraines to webinars — what have EPM readers clicked on this week?

Here we count down the top five tweets from @EPM_magazine that have gained the most impressions this week, taken from Twitter analytics.

5. Making it onto our list at number five is the announcement that the FDA has approved Amgen’s new preventative migraine treatment, Aimovig.

4. Number four for this week is the cover story from our latest May issue from Natoli, looking at how the right tooling can help overcome the challenges in tablet manufacturing.

3. Our recently published article from VWV looking at how pharma can learn from the collapse of the construction giant Carillion takes third place.

2. Coming in as our runner up is the announcement that the FDA has published a ‘name and shame’ list of those companies potentially using gaming tactics to delay generics.

1. This week’s top spot goes to the upcoming webinar from Thermo Fisher Scientific that will be hosted by us at EPM on how informatics can enforce lab best practices.